Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders

L Marandino; Joep de Jong; D Raggi; A Gallina; M Bandini; P Giannatempo; M Colecchia; A Briganti; F Montorsi; E Davicioni; R Seiler; P Black; EA Gibb; A Necchi

doi:10.1016/s0959-8049(20)31120-5

Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders

L Marandino, Joep de Jong, D Raggi, A Gallina, M Bandini, P Giannatempo, M Colecchia, A Briganti, F Montorsi, E Davicioni, R Seiler, P Black, EA Gibb, A Necchi

Urology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S21
Journal	European Journal of Cancer
Volume	138
DOIs	https://doi.org/10.1016/s0959-8049(20)31120-5
Publication status	Published - 2020

Research programs

EMC MM-03-49-01
EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0959-8049(20)31120-5

http://hdl.handle.net/1765/133790

Cite this

Marandino, L., de Jong, J., Raggi, D., Gallina, A., Bandini, M., Giannatempo, P., Colecchia, M., Briganti, A., Montorsi, F., Davicioni, E., Seiler, R., Black, P., Gibb, EA., & Necchi, A. (2020). Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders. European Journal of Cancer, 138, S21. https://doi.org/10.1016/s0959-8049(20)31120-5

@article{b904b1d51f2e46a7a0e2cd20ac6c83fe,

title = "Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders",

author = "L Marandino and {de Jong}, Joep and D Raggi and A Gallina and M Bandini and P Giannatempo and M Colecchia and A Briganti and F Montorsi and E Davicioni and R Seiler and P Black and EA Gibb and A Necchi",

year = "2020",

doi = "10.1016/s0959-8049(20)31120-5",

language = "English",

volume = "138",

pages = "S21",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Marandino, L, de Jong, J, Raggi, D, Gallina, A, Bandini, M, Giannatempo, P, Colecchia, M, Briganti, A, Montorsi, F, Davicioni, E, Seiler, R, Black, P, Gibb, EA & Necchi, A 2020, 'Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders', European Journal of Cancer, vol. 138, pp. S21. https://doi.org/10.1016/s0959-8049(20)31120-5

TY - JOUR

T1 - Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders

AU - Marandino, L

AU - de Jong, Joep

AU - Raggi, D

AU - Gallina, A

AU - Bandini, M

AU - Giannatempo, P

AU - Colecchia, M

AU - Briganti, A

AU - Montorsi, F

AU - Davicioni, E

AU - Seiler, R

AU - Black, P

AU - Gibb, EA

AU - Necchi, A

PY - 2020

Y1 - 2020

U2 - 10.1016/s0959-8049(20)31120-5

DO - 10.1016/s0959-8049(20)31120-5

M3 - Article

SN - 0959-8049

VL - 138

SP - S21

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -